Cancer Clinical Trials in New Haven, Connecticut

10 studies are recruiting for cancer in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

   This study will test the safety and effectiveness of a drug called IM-1617 in participants with solid tumors. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable). This study will have two parts. Part A will test in…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Yale Cancer Center, New Haven, Connecticut

   Locations

   4 in total

   Run by

   Immunome, Inc.

   See if you can join NCT07578571 on ClinicalTrials.gov

2. Statins to Prevent Cancer Associated Blood Clots

   Patients with cancer are at high risk for life-threatening venous thromboembolism (VTE) yet rarely receive anticoagulant prophylaxis due to bleeding risks. Thus, effective prophylaxis in oncology requires a method to reduce VTE without increasing hemorrhage. The primary aim of the Statin Therapy to…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Yale University, New Haven, Connecticut

   Locations

   9 in total

   Run by

   Brigham and Women's Hospital

   See if you can join NCT07303816 on ClinicalTrials.gov

3. Unified Network for Integrated Fluid Collection at Yale

   UNIFY is a Yale-wide liquid biopsy master repository that prospectively collects Streck-tube blood, dried blood spots (and optional archival tissue) from Yale Cancer Center patients across all tumor types for current and future research.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Smilow Cancer Hospital, New Haven, Connecticut

   Run by

   Yale University

   See if you can join NCT07689864 on ClinicalTrials.gov

4. FOG-001 in Locally Advanced or Metastatic Solid Tumors

   The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Yale University School of Medicine, New Haven, Connecticut

   Locations

   33 in total

   Run by

   Parabilis Medicines, Inc.

   See if you can join NCT05919264 on ClinicalTrials.gov

5. Pan Tumor Rollover Study

   Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Local Institution - 0095, New Haven, Connecticut

   Locations

   399 in total

   Run by

   Bristol-Myers Squibb

   See if you can join NCT03899155 on ClinicalTrials.gov

6. Evaluation of a Mobile App Program for Coping With Cancer

   The goal of this clinical trial is to learn if a mobile app program for people with a history of cancer can help treat distress. The main questions it aims to answer is: Do participants use the Tools for Coping with Cancer Calm Health mobile app and do they find it helpful? Does the Tools for Copin…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Smilow Cancer Hospital, New Haven, Connecticut

   Run by

   Yale University

   See if you can join NCT06923501 on ClinicalTrials.gov

7. Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

   The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropath…

   Stage

   Not phased

   Ages

   5 and older

   Site

   Yale New Haven Health Smilow York Street Hospital, New Haven, Connecticut

   Locations

   2 in total

   Run by

   Yale University

   See if you can join NCT07019259 on ClinicalTrials.gov

8. Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

   The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible…

   Stage

   Not phased

   Ages

   13 to 39

   Site

   Pediatric Hematology/Oncology Clinic in Smilow Cancer Hospital, New Haven, Connecticut

   Run by

   Yale University

   See if you can join NCT07224204 on ClinicalTrials.gov

9. Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

   The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the use of the RefleXion system to deliver intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), or SCINTIX Biology-guid…

   Stage

   Not phased

   Ages

   Any age

   Site

   Yale University - Cancer Center, New Haven, Connecticut

   Locations

   5 in total

   Run by

   RefleXion Medical

   See if you can join NCT05406167 on ClinicalTrials.gov

10. Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

    This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab [Gazyva®] pre-treatment, by IV infusion, and in combination with pembrolizumab. A Phase 2 monotherapy arm is also planned;…

    Stage

    Phase 1

    Ages

    18 and older

    Site

    Yale Cancer Center, New Haven, Connecticut

    Locations

    6 in total

    Run by

    Simcha IL-18, Inc.

    See if you can join NCT04787042 on ClinicalTrials.gov